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Abstract
Objective—Patients with chronic stroke have been shown to have failure to release
interhemispheric inhibition (IHI) from the intact to the damaged hemisphere before movement
execution (premovement IHI). This inhibitory imbalance was found to correlate with poor motor
performance in the chronic stage after stroke and has since become a target for therapeutic
interventions. The logic of this approach, however, implies that abnormal premovement IHI is
causal to poor behavioral outcome and should therefore be present early after stroke when motor
impairment is at its worst. To test this idea, in a longitudinal study, we investigated
interhemispheric interactions by tracking patients’ premovement IHI for one year following stroke.
Methods—We assessed premovement IHI and motor behavior five times over a 1-year period
after ischemic stroke in 22 patients and 11 healthy participants.
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Results—We found that premovement IHI was normal during the acute/subacute period and only
became abnormal at the chronic stage; specifically, release of IHI in movement preparation
worsened as motor behavior improved. In addition, premovement IHI did not correlate with
behavioral measures cross-sectionally, whereas the longitudinal emergence of abnormal
premovement IHI from the acute to the chronic stage was inversely correlated with recovery of
finger individuation.
Interpretation—These results suggest that interhemispheric imbalance is not a cause of poor
motor recovery, but instead might be the consequence of underlying recovery processes. These
findings call into question the rehabilitation strategy of attempting to rebalance interhemispheric
interactions in order to improve motor recovery after stroke.

Author Manuscript

It has been proposed that one contributor to chronic hemiparesis is an imbalanced inhibitory
interaction between the lesioned and intact hemispheres via transcallosal connections. This
interhemispheric-competition model proposes that the two hemispheres, which normally
exert mutual inhibition in healthy individuals, become imbalanced after stroke, and that
unopposed inhibition from the healthy to the damaged side impedes recovery.1 This
framework is largely based on a seminal study that showed persistent premovement
interhemispheric inhibition (IHI) from the contra- to ipsilesional motor cortex before
movement execution in patients with chronic stroke.2 This failure to release IHI before
movement onset (abnormal premovement IHI) correlated with weakness and impaired finger
tapping performance.2 Influenced by this stroke-recovery model, numerous studies in the
neurorehabilitation field have used different approaches (e.g. brain stimulation, peripheral
stimulation, and transient deafferentation) in an attempt to downregulate excitability in the
unaffected hemisphere and thus rebalance putative abnormal IHI (see recent studies3,4 and
reviews5–7).

Author Manuscript
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The problem with the interhemispheric-competition model is that abnormal premovement
IHI has only been described in patients with chronic stroke and relatively mild impairment.
Stinear and colleagues,8 using an indirect measure of IHI, recently found no evidence for
interhemispheric imbalance in the first 3 months after stroke. To date, it remains unclear
whether imbalanced interhemispheric interactions are present in the context of movement
early after stroke, whether they evolve over time, and whether they have any predictive value
for motor recovery. If interhemispheric interactions are normal early after stroke, then
designing rehabilitation strategies based on the interhemispheric-competition model is
questionable. Here, in a longitudinal observational study of patients with mild-to-moderate
hemiparesis, we investigated the evolution of premovement IHI over the first year after
stroke and related it to motor recovery of the hand. To this end, we followed the same
inclusion-exclusion criteria and procedures as the seminal study of Murase and colleagues.2

Participants and Methods
Participants
Twenty-two patients with hemiparesis from first-time ischemic stroke (7 female; mean age,
57.5 ± 16 years; 15 righthanded according to the Edinburgh Handedness Inventory9) were
recruited from three centers (The Johns Hopkins Hospital and Affiliates [JHM], Columbia
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University Medical Center [CU], and The University Hospital of Zurich & Cereneo Center
for Neurology and Rehabilitation [UZ]) for a prospective cohort study over the course of
four years. All patients met the following inclusion criteria: (1) first-ever ischemic stroke
confirmed by magnetic resonance imaging within the previous two weeks; (2) one-sided
upper extremity weakness (Medical Research Council <5). We excluded patients with the
following criteria: contraindications to magnetic stimulation, age <21 years, hemorrhagic
stroke, space-occupying hemorrhagic transformation, bilateral hemiparesis, traumatic brain
injury, encephalopathy, global inattention, visual-field cut larger than a quadrantanopia,
receptive aphasia, inability to give informed consent or understand the tasks, major
neurological or psychiatric illness that could confound performance/recovery, or a physical
or other neurological condition that would interfere with arm, wrist, or hand function
recovery. See Table 1 for details of patient characteristics.
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We also recruited 11 age-matched healthy control participants (4 female; mean age, 64 ± 9
years; all right-handed) at the three centers. All participants gave written consent and the
respective institutional research board at each study center approved all procedures. All
procedures were in compliance with the Declaration of Helsinki. All patients were tested at
five time points over a 1-year period (Table 2).
Assessment of Interhemispheric Inhibition with Transcranial Magnetic Stimulation

Author Manuscript

Transcranial Magnetic Stimulation Procedures And IHI Assessments—
Participants were comfortably seated in an armchair, arms resting on a pillow, and faced a
computer monitor. IHI was assessed by a double-pulse paradigm2,10 (Fig 1A), with two
figure-of-eight coils (diameters of wings 70 and 50 mm), each connected to a Magstim-200
magnetic stimulator (Magstim Co Ltd, Whitland, UK). The larger coil was placed
tangentially over the lesioned Ml (for testing stimulus [TS]), with the handle oriented toward
the back of the head and laterally at a 45-degree angle from the midsagittal line. The smaller
coil was oriented perpendicular to midsagittal line over the unaffected Ml (for conditioning
stimulus [CS]). For healthy age-matched controls, the CS was always applied to the right
M1 and the TS to the left M1, contralateral to the moving right hand. The positions of the
coils on the skull were adjusted to produce a maximal response in the contralateral first
dorsal interosseus (FDI) muscles (the hotspots). A frameless stereotactic neuronavigation
device (Brainsight; Rogue Research Inc, Montreal, QC, Canada) was used to track coil
positions within and across sessions.

Author Manuscript

Two stimulation conditions were used to calculate IHI: nonconditioned (NC) trials (NC: TSonly), where only a TS pulse was delivered, and conditioned (C) trials (C: CS + TS), where
a CS pulse was delivered before a TS pulse with an interstimulus interval (ISI) of 10 ms.
Conditioned and unconditioned trials were intermixed and randomized throughout the
testing session.
IHI was assessed in two contexts: at rest (resting) and during movement preparation
(premovement). Following a previous study, IHI at rest was obtained in order to determine
the stimulation parameters for premovement IHI.2 For resting IHI, intensities of TS and CS
were first set at the minimum level of maximal stimulator output (MSO) that produced a
contralateral motor-evoked potential (MEP) with amplitude 0.5 to 1.0 mV. CS intensity was
Ann Neurol. Author manuscript; available in PMC 2020 July 22.
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then adjusted to produce a ~50% reduction in TS-MEP amplitude. The resting-IHI
assessment consisted of a block of 36 trials with 18 each for NC and C stimulation.

Author Manuscript

During the premovement IHI task, while the participant performed a simple reaction-time
(RT) task, a transcranial magnetic stimulation (TMS) pulse was then delivered on each trial
at four possible epochs: 20, 50, 80, and 95% of each participant’s RT (see the section below,
Fig. 1B). TS intensity was determined in the same way as for resting IHI. To assess CS
intensity in the context of movement execution, participants were asked to perform the same
RT task when double-TMS pulses were delivered at an estimated 50% of RT on each trial,
and CS intensity was adjusted to the level approximating 50% of the TS-MEP. This
adjustment was to probe the largest possible dynamic range of CS modulation during
premovement IHI testing. As described previously,2 when probed at different times during
the RT, a healthy control’s typical IHI curve shows an initial reduction, followed by
increases of MEP when stimulation is delivered closer to movement onset, that is, IHI
switches to facilitation (release of inhibition).
A total of six blocks, with 24 premovement IHI trials per block, were run in each testing
session, with 18 pulses per stimulation/time-epoch condition. Sessions were not run if
patients could not abduct their index finger or if the stimulation intensity was too high to
obtain both resting and premovement IHI (required >90% MSO to elicit an MEP >0.5 mV).
These patients were still included in the study if IHI could be obtained in subsequent visits.
Resting motor threshold (rMT) for both FDIs were determined as the minimal TMS intensity
required to evoke MEPs of ~50 μV (peak-to-peak amplitude) in the targeted muscle on five
of ten consecutive trials.

Author Manuscript

Because MEP amplitudes increase in the moving effector immediately before movement
onset, leading to large MEP that can mask the true size of release of inhibition (or
contralateral facilitation), we compared MEP amplitudes recorded during the premovement
IHI procedure with maximal amplitudes obtained in each participant using assessment of
active corticospinal tract (aCST). This was done with 18 single pulses delivered at 100%
MSO with an ISI of 5 to 7 seconds, while the participant was actively contracting the
contralateral FDI at a constant level of 20% of their maximum voluntary contraction force.

Author Manuscript

EMG Recording—Electromyogram (EMG) activity was monitored from surface
electrodes placed over the FDI in both hands. Three EMG systems were used at the three
sites: SX230–100 and K800, Biometrics Ltd. (CU); AMT-8; Bortec Biomedical Ltd. (JHM);
and Telemyo desk receiver, Noraxon (UZ). The Biometrics EMG signal was sampled at
1,000 Hz, amplified 1,000×, band-pass filtered at 15 to 450 Hz; the AMT-8 EMG signal was
sampled at 1,000 Hz, amplified 1000×, band-pass filtered at 10 to 1,000 Hz; and the
Noraxon EMG was sampled at 1,500 Hz, amplified 500×, band-pass filtered at 15 to 450 Hz.
EMG signals were used to determine RTs and MEP amplitudes (see below the Measures of
Premovement IHI section).
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Premovement IHI was assessed while participants performed a simple RT task. The
participants were instructed to make a voluntary index-finger abduction in response to a GOcue (green dot). Patients used their paretic hand, whereas healthy volunteers always
performed the task with their right hand. The GO-cue was displayed on the monitor for 2
seconds and disappeared at the end of the trial. The intertrial interval was 5 seconds plus 0 to
2 seconds of jitter to prevent anticipation.
Before the IHI procedure, each participant performed the simple reaction task for 30 trials to
determine their average RT. The last 15 trials were used to calculate the RT.
Stroke-Related Behavioral Assessments

Author Manuscript

All patients’ and controls’ upper-extremity motor impairment was determined with the FuglMeyer Assessment (FMA),11 following the same schedule as premovement IHI. Hand
function was also tested within ±4.6 days from the TMS experiment, as previously
described.12 Briefly, participants were instructed to move each finger in isolation on an
ergonomic device that measures the isometric force generated by each digit. A strength
index was calculated from the maximum voluntary force (MVF) of individual finger flexion,
normalized to the MVFs on the nonparetic side at the 1-year time point. An individuation
index was derived from the activation in the noninstructed fingers as a function of force
produced by the instructed finger pressing to four levels of target forces.
Measures of Premovement IHI
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EMG was used to measure RT and peak-to-peak amplitudes of the MEPs elicited in FDI of
both hands. Both RTs and MEPs were identified using custom-made MATLAB scripts (The
MathWorks, Inc., Natick, MA) from the EMG recordings. The RT was manually identified
with the following criteria: peak-to-peak waveforms of EMG activity >100 μV and lasting
longer than 50 ms following the GO-cue.
The following trial types were excluded from further analysis: (1) trials with any background
EMG activity >20 μV in the 150-ms window preceding the TMS pulse in either FDI; (2)
MEP size <50 μV; (3) MEP occurrence after movement onset; and (4) RT >1,000 ms. An
analysis of the background pretrigger EMG across different TMS epochs was also conducted
to rule out the potential influence of systematic differences in background EMG on the
premovement IHI results.

Author Manuscript

Resting and premovement IHI was computed as the ratio C/NC. An IHI ratio of 1 indicates
no IHI. To prevent averaging epochs with too few MEP observations, a minimum of nine
good MEPs (one-half of the total count) was required to compute the ratio. A good TS-MEP
was defined as: (1) no background EMG activity in the 150-ms window before the TMS
pulse; (2) the MEP occurred before movement onset; (3) peak-to-peak amplitude was >50
μV; and (4) distinct movement is detectable (EMG >100 μV for >50 ms) within 1,000 ms
after the GO-cue. TMS timing epochs with less than nine good MEPs were counted as
missing values. To evaluate the reproducibility of the IHI ratio as the main dependent
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variable in this study, we computed its Cronbach’s alpha.13,1 Mathematically, alpha is
equivalent to the averaged split-half correlation of all possible splits of the existing data:
a=

1
Nall splits

Nall splits

∑

i=1

ri .

Author Manuscript

To assess the evolution of IHI during movement preparation, we derived three other
measures: IHIEARlY-EPOch = mean (IHI20 % RT IHI50 % RT), IHILATE-EPOCH = mean
(IHI80 % RT IHI95 % RT), and ΔIHI = IHIlate-epoch – IHIearly-epoch ΔIHI therefore reflects the
amount of release of IHI during movement preparation. A value of ΔIHI = 0 indicates no
modulation of inhibition,15 whereas a positive value implies a release of inhibition during
movement preparation. Hereinafter, we will use ΔIHI as an operational definition of
premovement IHI to refer to the level of release of inhibition preceding movement onset.
Statistical Analysis

Author Manuscript
Author Manuscript

Data analysis was done with custom-written MATLAB and R (R Core Team, 2017) routines.
Given that there were missing sessions (on average, each patient completed 3.4 sessions and
each healthy control completed 3.5 sessions, out of a total of 5), we used two analysis
approaches: (1) For the primary analysis, we assumed missing ΔIHI values arose at random
(MAR) and used linear mixed-effects models implemented in the lme4 package in R16 to
test for changes in the neurophysiology and behavioral measures over time, with a random
factor of Subject, and fixed factors of Time-Point (five time points from W1 to W52, or
acute/subacute versus chronic), Hand-Condition (paretic, nonparetic, and/or control), and/or
TMS-Epoch (early versus late TMS timing). (2) Because there are cases where data were
missing due to severity of impairment, specifically when there was no reliable finger
abduction and/or MEP at a given assessment session (Table 2), there was a concern about the
possibility of a systematic relationship between premovement IHI and missingness. We
therefore conducted a sensitivity analysis by imputing missing values under different datagenerating mechanisms. Specifically, for all missing values belong to the category of
severity dependent (Table 2) we implemented the assumptions of either no dependency or
strong dependency between premovement IHI and the severity of initial impairment (Fig
3D,E). No dependency mimics the MAR assumption of the mixed model, with imputed
samples drawn from N~(μ(t,patient), σ(t,patient)), Where μ(t,patient) and σ(t,patient) are estimated
from patient data at each time point; whereas strong dependency represents a scenario in
which severely affected patients have ΔIHI values centered at 0, with imputed samples from
N~(0, σpatient), where σpatient is estimated from all patients’ data. For each data set
containing imputed values, we fit the linear mixed model as specified above to account for
other missingness. Analysis of variance (ANOVA) tests for sensitivity analyses were
conducted by pooling significance tests of multiply-imputed data sets.17
For behavioral results, we included all available behavioral data, including the sessions in
which we could not obtain IHI.
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Results
We tested a total of 22 patients from the acute to chronic stages after stroke and 11 healthy
controls. Each participant was expected to undergo five testing sessions over the course of a
1-year period. One patient appeared to meet initial inclusion criteria, but was later found to
have bilateral strokes and was excluded from further analysis. The final analysis included a
total of 110 premovement IHI sessions from 21 patients and 11 controls. Thirteen patients
and eight controls completed ≥3 sessions. The distributions of assessment time and missing
data are presented in Table 2. Nontested sessions were treated as missing data, and all
available data were used in the statistical analyses. The data showed good reliability for the
major dependent variable, IHI ratio (α = 0.74 and 0.79 for patients and controls,
respectively; Participants and Methods). Figure 2 shows the distribution of lesions defined
using diffusion tensor images (details reported in our earlier publication12).

Author Manuscript

Premovement IHI Changed from Normal to Abnormal as Paresis Improved from the Acute
to the Chronic Stage

Author Manuscript

Our main goal was to determine how IHI before movement onset evolves over the first year
after stroke and how this relates to motor recovery. Figure 3A shows a representative
patient’s IHI curves at the acute/subacute and chronic stages, as compared to a healthy agematched control. Figure 3B,C shows the group data for controls and patients. Visual
inspection of these curves suggests that, consistent with the previous report by Murase and
colleagues,2 patients in the chronic stage had an abnormal IHI pattern, characterized by the
absence of release of inhibition at movement onset. Crucially, however, in the acute/subacute
period (W1–12) release of IHI at movement onset in patients did not appear to differ from
controls. Specifically, the IHI ratio at weeks 1 to 12 poststroke increased over the
movement-preparation interval, approaching a ratio of 1 at later stimulation epochs (80–95%
RT), indicating a level of release of inhibition before movement onset similar to healthy
controls.

Author Manuscript

Given that in previous reports, and corroborated here, the poststroke abnormality in
premovement IHI is most apparent at movement onset, our statistical analyses focused on
ΔIHI, as in earlier studies.15,18 ΔIHI is the difference between IHIlate-epoch and IHIearly-epoch,
which captures the level of release of IHI immediately preceding movement onset
(Participants and Methods). An ANOVA using a mixed-effects model for ΔIHI yielded a
significant Week × Group (patients versus controls) interaction (χ2 = 4.59; p = 0.03). The
evolution of ΔIHI from the acute/subacute to the chronic stage after stroke clearly showed
that at earlier stages (W1–12), patients and controls were similar (t(21) = 0.50; p = 0.62),
whereas the two groups started to diverge from W24 onward (t((31)= 3.30, p = 0.0025; Fig.
3D). Our sensitivity tests also indicate that this trend is robust to the differences in the datagenerating mechanisms considered (p = 0.028 for MAR and p = 0.10 for informed
missingness; Fig. 3D,E, Participants and Methods). To directly compare ΔIHI in the acute
versus the chronic stage, we pooled data into two Time-periods: mean (W1–12; acute/
subacute for patients) and mean (W24–52; chronic for patients). This data pooling was
further supported by our observation that there was no difference in patients’ ΔIHI from W1
to W12 (p = 0.17) or from W24 to 52 (p = 0.70). The mixed-effects model with Time-period
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and Group (patients versus controls) as fixed factors showed a significant interaction (χ2 =
6.68; p = 0.01). These results show that patients’ premovement IHI progressed from normal
in the acute/subacute period to abnormal in the chronic stage in the case of mild-to-moderate
paresis (Fig. 3F).
The Development of Abnormal Premovement IHI Was Inversely Correlated with the Extent
of Finger Individuation Recovery
Our cohort of patients was mild to moderately impaired in the acute stage (FMAinitIal Mean
= 41 ± 22; Table 1). Motor recovery was quantified using three behavioral measures: FMA,
Strength and an Individuation Index for finger (ability to move digits independently;
Participants and Methods).12 All three measures showed good early recovery (Strength: χ2 =
28.07; p < 0.001, Individuation: χ2 = 13.64; p < 0.001, and FMA: χ2 = 28.07; p < 0.001),
but then plateaued after the subacute stage (Fig 4).

Author Manuscript

We then sought to determine whether there was any correlation between abnormal
premovement IHI and motor behavior. To address this question, we first examined the crosssectional correlation between ΔIHI and all three behavioral measures at both the acute/
subacute and chronic stages; none of the correlations were significant with the null value (0)
lying within 95% confidence intervals (CIs; Table 3). Thus, there was no clear relationship
between abnormal premovement IHI with strength, individuation, or motor impairment at
any time point.

Author Manuscript
Author Manuscript

Both the opposite longitudinal time courses for motor recovery and development of
abnormal premovement IHI and the lack of significant cross-sectional correlation between
the two suggest that the premovement IHI abnormality was not causally related to behavioral
impairment. Instead, the emergence of abnormal premovement IHI (failure-to-release
inhibition during movement preparation) may be a marker for underlying recovery processes
(see Discussion). To address this alternative possibility, we examined the correlation
between longitudinal motor-function recovery (change in behavior) and the emergence of
the failure-to-release IHI (reduction in ΔIHI) from the acute/subacute to the chronic stages.
We found a strong negative correlation between the reduction of ΔIHI and the amount of
improvement in the individuation index (r = −0.73; p = 0.003; 95% CI, [−0.91, −0.33]). This
suggests that the emergence of failure-to-release IHI during movement preparation and poor
finger-individuation recovery share a latent cause. We did not find a significant correlation
between changes in ΔIHI and changes in the Strength Index (r = 0.22; p = 0.44; 95% CI,
[−0.35, 0.67]; Fig. 5). This observation is consistent with the fact that by week 52 at the
group level, patients’ strength was not far from healthy levels (t (26) = 1.43; p = 0.16), but
finger individuation was (t (26) = 2.43; p = 0.02).
Other TMS and Behavioral Measures
In addition to premovement IHI, we also measured the participants’ rMT, aCST, and restingIHI for the FDI muscle (Participants and Methods). Results from these measures are
reported in Table 4. Consistent with the previous literature,2,19 IHiREST in patients and
controls did not differ. Patients and controls had comparable TS- and CS-stimulation
intensities for both resting and premovement IHI. For rMT, we included sessions when
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premovement IHI was not obtainable, and consistent with earlier reports,8,20 the results
showed higher rMT on the lesioned hemsphere, reflecting lower level of Ml output at acutesubacute stages in severely impaired patients.
To ensure our premovement IHI results were not attributed to high MEP amplitudes,
especially during the later TMS epochs, we compared the MEP sizes obtained from aCST
with the single-pulse TS at late TMS epochs (80 and 95% RT; Participants and Methods). If
TS-MEPs approach the MEP amplitudes of the aCST, when MEP amplitudes are expected to
be near maximal, the amount of IHI modulation during movement preparation could lack
sufficient dynamic range or be masked. We found, however, that most late-epoch MEP
amplitudes were lower than those obtained during the aCST assessment (see statistics in
Table 4).

Author Manuscript

It might be posited that one way that failure-to-release inhibition might influence behavior is
to prolong the RT. We therefore examined the relationship between the RT and premovement
IHI in the simple RT task. RTs in patients were prolonged compared to controls (Fig 6A,B;
χ2 = 9.19; p = 0.002), but this prolongation was not linked to changes in premovement IHI:
There was no interaction with ΔIHI and RT (χ2 = 0.31;p = 0.58).

Author Manuscript

To rule out the possibility of background EMG influencing the observed premovement IHI
patterns, we also performed a mixed-effect model analyses on pretrigger EMG (Participants
and Methods). Results showed that background EMG was higher in healthy controls (χ2 =
5.46; p = 0.019) and decreased over time in both groups (χ2 = 45.23; p = 1.77 X e−11),
possibly attributed to participants becoming more acquainted with the testing procedure (Fig
6C,D). Critically, there was no main effect of conditioned (C) versus nonconditioned (NC)
trials, nor any interaction between group and any other factor. Thus, differences in
background EMG cannot explain the premovement IHI findings.
Finally, age did not influence the main dependent variable ΔIHI (χ2 = 0.53; p = 0.47), nor
did it interact with Week (χ2 = 4.73; p = 0.09). Similarly, age also did not modulate the
behavioral outcome variables in our cohort: Strength, Individuation, FMA, and ARAT.

Discussion

Author Manuscript

In a longitudinal multicenter study, we tracked the evolution of premovement IHI from
stroke onset up to 1 year. We used a double-pulse TMS paradigm to test patients and healthy
controls at five time points: week 1, 4, 12, 24, and 52. We also tracked patients’ finger
strength and individuation, and overall motor impairment (FMA). We found that release of
IHI before movement onset was normal in the acute/subacute period and became abnormal
in the chronic stage. Conversely, behavioral outcomes were most impaired in the acute/
subacute period and improved over time to reach plateau in the chronic stage. In addition to
these opposite longitudinal trends for the physiological and behavioral measures, we found
no significant cross-sectional correlations between premovement IHI and behavioral
measures in the patients (strength and individuation). The only significant correlation was an
inverse relationship between the development of abnormal premovement IHI from the acute/
subacute to the chronic stage after stroke (i.e. the emergence of the failure-to-release IHI
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before movement onset) and the amount of recovery in finger individuation across the same
period.

Author Manuscript

In the seminal study by Murase and colleagues,2 impaired premovement IHI was found in
nine patients with chronic stroke. This study has become highly influential and, in our view,
was prematurely interpreted by the overall neurorehabilitation field as suggesting a possible
causal relationship between IHI and recovery of motor impairment. This interpretation is
problematic because: (1) premovement IHI is only one kind of interhemispheric measure; it
is possible to assess IHI at other ISIs or interhemispheric facilitation.21 (2) Premovement IHI
is only obtainable in patients with detectable MEPs and finger movements; it cannot be
assessed in patients with more severe motor deficits. (3) The study by Murase and
colleagues had a small sample of patients at only one time point in the chronic stage, which
makes inference about changes over time, or recovery, impossible. The overinterpretation of
the Murase and colleagues results led, in turn, to a large number of studies that attempted, or
claimed, to rebalance IHI using noninvasive brain stimulation (NIBS) in the acute and
chronic stages after stroke.22–26 What should have been established first, in our view, is the
time course of the development of premovement IHI abnormality from the acute/subacute
period to the chronic stage.

Author Manuscript

The critical finding reported here is that in the acute/subacute period, in those patients that
could be assessed with this TMS technique, we found normal modulation of premovement
IHI despite their motor deficits. Failure-to-release premovement IHI only emerged in the
chronic stage, whereas the behavioral measures all improved over the same time period. This
diametric contrast makes any claim to a causal relationship between abnormal premovement
IHI and the motor deficit implausible. Adding to this, we found no significant crosssectional correlations between premovement IHI and severity of paresis, assessed by FMA,
Strength, or Individuation. Admittedly, given the limited statistical power, we cannot
definitively rule out the possibility of an association between premovement IHI and a
clinical measure. Interestingly, though, a recent meta-analysis27 of 112 TMS studies
concluded that “there is no clear evidence for hyper-excitability of the unaffected
hemisphere” in either the acute or chronic phases after stroke. Nevertheless, it is important
to note that the interpretation of our results, as well as of previous investigations, should be
limited to those patients for whom it is possible to assess premovement IHI and/or obtain
MEPs (i.e. those with mild-to-moderate motor deficits). Therefore, it remains unclear what
the interhemispheric interaction would be for patients with more severe motor deficits.

Author Manuscript

It would be puzzling, however, if premovement IHI were to be abnormal in the acute period
in severe patients given that our mild-to-moderate patients showed improvement from
paresis as IHI became worse. Thus, from parsimony, it would seem that the interhemispheric
competition model would not be a satisfactory causal explanation even in patients with
severe motor deficits. Unfortunately, methodological limitations prevent us from going
beyond this speculation.
The inverse correlation between the emergence of abnormal premovement IHI from the
acute/subacute to chronic stages and recovery of individuation suggests that, rather than any
direct causal relationship between them, the development of an abnormal pattern of ΔIHI
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over time might provide an indirect measure of the state of longitudinal recovery. This
would mean that the amount of reduction in ΔIHI might reflect a less-optimal form of
reorganization, such as a reliance on contralesional corticoreticular projections28,29 or,
possibly, the consequence of decreasing use of the paretic hand in dexterity-requiring tasks.
Both possibilities are consistent with the finding that finger individuation did not fully
recover even at 1 year after stroke (Fig 4B). We cannot disambiguate these two possibilities
in this study. However, here we show: (1) There is no cross-sectional correlation between
premovement IHI and behavior; (2) behavior gets better as premovement IHI gets worse;
and (3) the emergence of abnormal premovement IHI is correlated with poor fingerindividuation recovery. These results together suggest that the abnormal interhemispheric
interaction in the chronic stage might be the consequence of, and a marker for, the state of
recovery of the brain rather than the cause of impairment. Therefore, it is questionable that
interhemispheric imbalance should be a therapeutic target.

Author Manuscript
Author Manuscript

The results presented here challenge the validity of the interhemispheric-competition
recovery model. This is important given that in the past decade, numerous studies have used
NIBS in an attempt to downregulate the contralesional hemisphere to promote recovery:
From 2005 to 2016, there were 45 published clinical trials using cathodal transcranial direct
current stimulation25 and 25 trials up to May 2014 using rTMS.26 The lasting impact of the
model is apparent in a recent influential perspective by Di Pino et al,7 in which they
introduce a hybrid recovery model that combines vicariation in the ipsilesional hemisphere
with interhemispheric-competition. Of note, our results do not negate the fact that on
occasions, NIBS over the ipsi-, contra-, or bilateral hemisphere have shown beneficial
effects.3,4 What our results do indicate, however, is that any beneficial effect of NIBS is not
likely operating by an IHI mechanism, at least for patients with mild-to-moderate
hemiparesis.
In conclusion, the results reported here cast doubt on the validity of the interhemisphericcompetition model. Future investigations using noninvasive brain stimulation, or other
interventions, such as peripheral nerve stimulation, to improve recovery following stroke
will require alternative mechanistic justification.
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FIGURE 1:

Schematic illustration of the premovement Interhemispheric Inhibition (IHI) paradigm. (A)
A test stimulus (TS) was delivered over the lesioned hemisphere, and a conditioning
stimulus (CS) was applied over the intact hemisphere before index finger abduction of the
paretic hand (or right hand in healthy age-matched controls). In nonconditioned (NC) trials,
only the TS was delivered, whereas in conditioned (C) trials, the CS preceded TS by 10 ms.
EMG signals were recorded from the first dorsal interosseous muscle (FDI) of the moving
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hand. (B) TMS pulses were delivered at four timing epochs relative to the individual’s mean
reaction time, estimated from a simple-reaction task. EMG = electromyography.
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FIGURE 2:

Lesion distribution of patients (N = 21). Averaged lesion distribution mapped to JHU-MNI
space,30 with lesion flipped to one hemisphere. Color bar indicates patient count.
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FIGURE 3:
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Release of IHI before movement onset. (A) IHI curves for a representative patient and a
healthy control. These exemplar IHI profiles illustrate the normal release of IHI in patients at
the acute/subacute stage, comparable to control subjects, and the lack of normal release of
IHI during the chronic period. (B) Overall mean IHI curves for healthy controls. Because
there were no differences over time in premovement IHI in controls (mixed-effects model
with Week and TMS-Timing as fixed factors showed no significant effect of Week, χ2 =
0.067, p = 0.80, but significant main effect of TMS-Timing, χ2 = 22.28, p < 0.001), we
averaged control data across weeks. (C) IHI curves for each time point over the 1-year
period for patients. (D) Evolution of ΔIHI for patients and controls over the 1-year period.
Patients showed close to control level of ΔIHI in the acute/subacute periods (W1–12), but
their ΔIHIs became abnormal at the chronic stage. Shaded plots in gray and red are
sensitivity analysis with two imputation schemes with MAR and informed-missingness
cases, respectively, where missing not at random (MNAR) cases are imputed with 1,000
samples from N~(μ(t,patient), σ(t,patient)) or N~(0, σpatient). (μ(t,patient) and σ(t,patient)) are
estimated from patients data at each time point and σpatient is estimated from all patients’
data. (E) Distribution of p values from sensitivity analysis with multiple imputation for the
MAR and informed-missingness cases. (F) Change of IHI level at different movement
preparation epochs in patients from the acute/subacute to chronic stage after stroke. There
was a significant interaction of IHIEARLY-EPOCH vs IHILATE-EPOCH or acute/subacute and
chronic stages (χ2 = 4.34, p = 0.037), but no differences when comparing across acute/
subacute vs chronic stages for IHIEARLY-EPOCH (t(14) = 0.75; p = 0.47) or IHILATE-EPOCH
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(t(14) = 1.69; p = 0.11). Means and variances in all plots were estimated by mixed models.
IHI = interhemispheric inhibition; TMS = transcranial magnetic stimulation.
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FIGURE 4:

Recovery curves for behavior measures of hand function over 1-year period, from week 1 to
52. (A) Strength indices. (B) Individuation indices. (C) FMA. Means and variances are
estimated by mixed model. FMA = Fugl-Meyer Assessment.
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FIGURE 5:

Correlations between the reduction of premovement IHI (ΔIHI) from acute/subacute to
chronic stages and the amount of behavioral recovery: (A) Strength; (B) Individuation. xand y-axes are the mean differences between chronic and acute/subacute behavior measures
and ΔIHI, respectively.
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FIGURE 6:
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Other behavioral and physiological measures in premovement experiments. Reaction time
(RT) for patients (A) and controls (B) at different TMS timing during movement preparation
across the 1-year period. RTs for controls were overall faster than patients. Background
EMG for patients (C) was overall lower than that in controls (D), but was at a similar level
for conditioned vs nonconditioned TMS stimulation. RMS = root mean square; TMS =
transcranial magnetic stimulation.
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4 (19%)
3 (14%)
6 (29%)
2 (10%)

MEP count <9 (late TMS epochs)

No MEP

TS >90% MSO

No reliable movement

Other missing

0 (0%)

3 (14%)

4 (19%)

2 (10%)

1 (5%)

1 (5%)

11 (52%)

13 (62%)

34 ± 5

4 to 6

W4

3 (14%)

2 (10%)

2 (10%)

0 (0%)

1 (5%)

1 (5%)

12 (57%)

14 (67%)

93 ± 8

12 to 14

W12

3 (14%)

0 (0%)

0 (0%)

0 (0%)

2 (10%)

0 (0%)

16 (76%)

18 (86%)

184 ± 12

24 to 26

W24

5 (24%)

0 (0%)

0 (0%)

0 (0%)

1 (5%)

0 (0%)

15 (71%)

16 (76%)

369 ± 10

52 to 54

W52

IHI = interhemispheric inhibition; MEP = motor-evoked potential; MSO = maximal stimulator output; RT = reaction time; TMS = transcranial magnetic stimulation; TS = test stimulus.

The first two rows are the number of weeks and days poststroke at each time point of assessment. The following two rows are patient counts with obtained data. The following six categories are counts of
missing data for various reasons: MEP count <9 at early TMS epochs (20 and 50% RT) are likely attributed to lack of big enough MEP size (>50 μV), whereas those at late TMS epochs (80 and 95% RT)
are likely attributed to TMS pulses occurring during the movement; “No MEP” or “TS >90% MSO” can sometimes be overlapping with “No reliable movement (index finger abduction)” count in cases of
complete plegia; “Other missing” cases include data missing for random reasons: missed the time window, patient dropped out of the study, patients refused to continue the session, or technical issues
during the session. Percentages out of the total N = 21 are presented in parentheses.

0 (0%)
2 (10%)

MEP count <9 (early TMS epochs)

8 (38%)

ΔIHI obtained

IHI obtained

10 (48%)

12 ± 3

No. of days post stroke

No. of patients

1 to 2

W1

No. of weeks post stroke

Total N = 21
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0.06 [−0.50, 0.40]

Chronic (W24–52)

0.16 [−0.32, 0.57]

0.46 [−0.05, 0.78]

Strength

0.43 [−0.03, 0.74]

0.22 [−0.31, 0.65]

Individuation

IHI = interhemispheric inhibition; FMA = Fugl-Meyer Assessment.

Table shows Pearson r values; parentheses represent the 95% confidence interval for each correlation coefficient.

0.47 [−0.03, 0.78]

Acute/subacute (W1–12)

FMA

Cross-Sectional Correlations Between Release of IHI Before Movement Onset (ΔIHI) and Behavioral Measures, FMA, and Strength and Individuation
Indices, at Acute/Subacute and Chronic Stages
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IHIR

0.69 (0.20)

0.59 (0.26)

IHIrest

Patient

Control

0.73 (0.29)

0.67 (0.19)

4

0.73 (0.44)

0.81 (0.16)

12

58 (8)

Control

49 (10)

57 (15)
49 (4)

53 (13)

CS Stimulus Intensity (% MSO)

56 (17)

56 (8)

Patient

Control

49 (4)

55 (18)

52(7)

Control

48 (6)

52 (16)
50(6)

60 (19)
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2.51 (1.07)
1.82 (0.91)

2.22 (1.46)

1.81 (1.06)

rMT

62 (24)

42 (11)

TS at 95% RT

TS at 80% RT

Patient

Paretic

Non-paretic

42(7)

40 (6)

1.87 (0.07)

41 (6)

2.43 (0.02*)

42(7)

43 (9)

45(7)

Non-dominant

45 (8)

2.74 (0.009*)

1.20 (0.24)

48 (9)

3.34 (0.002*)

1.95 (0.06)

46 (8)

2.74 (0.01*)

3.11 (0.005*)

2.08 (0.046*

0.51 (0.62)

2.72 (0.01*)

2.13 (0.04*)

1.12 (0.28)

0.70 (0.49)

0.79 (0.44)

0.65 (0.53)

0.11 (0.56)

12

1.91 (0.07)

0.60 (0.55)

1.12 (0.28)

0.61 (0.55)

1.21 (0.24)

0.60 (0.56)

Paretic vs Nonparetic

1.97 (0.06)

1.05 (0.31)

aCST vs TS

0.35 (0.73)

0 (1.00)

0.19 (0.85)

0.15 (0.88)

0.81 (0.44)

47(7)

40 (10)

46 (13)

1.55 (0.81)

1.81 (0.99)

3.27 (2.12)

4

Patient vs Control

1

Dominant

40 (10)

47 (14)

1.33 (1.23)

1.68 (1.32)

2.78 (1.53)

53 (12)

56 (14)

56 (15)

54 (14)

60 (12)

57 (17)

56 (15)

55 (16)

0.70 (0.22)

0.73 (0.25)

52

Paretic vs Control

40 (9)

50 (13)

1.64 (1.26)

2.00 (1.28)

3.27 (1.80)

58(9)

60 (18)

56 (14)

58 (16)

63 (11)

63 (18)

56 (14)

55 (15)

0.78 (0.32)

0.79 (0.20)

24

t Testst- Value (p)

Control

40 (9)

54 (21)

3.71 (1.99)

2.89 (1.36)

aCST

MEP Amplitude in Patient (mV)

55 (18)

Patient

TS Stimulus Intensity (% MSO)

50 (10)

57 (16)

54 (8)

IHIpremove

54 (7)

59(9)

60 (16)

Control

59 (20)

57 (19)

Patient

TS Stimulus Intensity (% MSO)

57 (17)

Patient

CS Stimulus Intensity (% MSO)

1

Week

Author Manuscript

Mean (SD)

Author Manuscript

Other Basic TMS Measures

1.19 (0.24)

0.42 (0.68)

1.70 (0.10)

3.10 (0.004*)

2.28 (0.03*)

0.32 (0.75)

0.23 (0.82)

0.01 (0.99)

0.20 (0.84)

0.11 (0.91)

24

1.42 (0.167)

0.25 (0.81)

1.48 (0.15)

3.02 (0.005*)

2.48 (0.02*)

0.50 (0.62)

0.30 (0.77)

0.40 (0.69)

0.08 (0.94)

0.35 (0.73)

52
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= statistically significant.

*

TMS = transcranial magnetic stimulation; IHI = interhemispheric inhibition; CS = conditioning stimulus; TS = testing stimulus; RT = reaction time; MSO = maximal stimulator output; MEP = motorevoked potential

nonparetic hands in patients, and dominant versus nondominant hands in healthy controls.

integrity (aCST) assessed with 100% MSO, TS at 95 and 80% of RT, and resting motor threshold (rMT) in patients and controls. Independent-samples t tests were done between patients and controls for
IHIrest and CS and TS intensities at each time point. MEP amplitudes were compared between aCST and TS at each time point among patients. Comparison of rMT were done between paretic versus

Reported here are mean and standard deviations (SD) of IHI at rest (IHIrest), CS and TS stimulation intensities for resting and premovement IHI, MEP amplitude in patients for active corticospinal track
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